MAINtenance of Remission Using RITuximab in Systemic ANCA-associated Vasculitis
Latest Information Update: 07 Nov 2023
At a glance
- Drugs Rituximab (Primary) ; Azathioprine; Cyclophosphamide; Prednisone
- Indications Granulomatosis with polyangiitis; Microscopic polyangiitis
- Focus Registrational; Therapeutic Use
- Acronyms MAINRITSAN
- 02 Nov 2023 Results of pooled analysis from MAINRITSAN, MAINRITSAN 2 and MAINRITSAN 3, published in the Annals of the Rheumatic Diseases
- 14 Nov 2022 Results of pooled analysis assessing long term outcome using data from MAINRITSAN trials, presented at the ACR Convergence 2022.
- 06 Jun 2020 Results presented at the 21st Annual Congress of the European League Against Rheumatism